Overview

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the relationship between insulin resistance and non-alcoholic fatty liver disease (NAFLD) and to investigate potential mechanisms underlying insulin resistance in NAFLD by determining associations between hepatic and peripheral insulin sensitivity, hepatic steatosis, dyslipidemia, inflammatory cytokines, glucose metabolism, beta-cell function and body fat distribution.
Phase:
N/A
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Fenofibrate
Insulin
Pioglitazone